Grabar Law Office Investigates Claims on Behalf of Shareholders of Wheels Up Experience, Inc. (UP)
Philadelphia, Pennsylvania--(Newsfile Corp. - October 11, 2023) - Federal securities fraud complaints allege that the Wheels Up (NYSE: UP), via certain of its officers and directors, made materially false and/or misleading statements and/or failed to disclose that: (1) Wheels Up failed to address any material weaknesses with internal controls; (2) Wheels Up's financial statements from September 30, 2022 to the present included "certain errors" such as understating net loss and overstating...
2023-10-11 9:35 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Sotera Health Company (SHC)
Philadelphia, Pennsylvania--(Newsfile Corp. - October 11, 2023) - Grabar Law Office is investigating potential claims on behalf of Sotera Health Company (NASDAQ: SHC) shareholders. The investigation concerns whether certain officers of Sotera have breached their fiduciary duties owed to the company. A class action complaint has been filed against Sotera Health. The complaint alleges that the Company, via certain officers and directors, made numerous materially false and misleading...
2023-10-11 8:25 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of UiPath Inc. (PATH)
Philadelphia, Pennsylvania--(Newsfile Corp. - October 11, 2023) - A recently filed securities fraud class action complaint alleges that UiPath Inc. (NYSE: PATH), via certain of its officers and directors made false and/or misleading statements and/or failed to disclose that: (i) UiPath had enacted a widespread discounting program prior to its IPO, which had the effect of temporarily boosting UiPath's revenue and annualized recurring revenue metrics, cannibalizing its future sales, eroding...
2023-10-11 8:06 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Integra Lifesciences Holdings Corporation (IART)
Philadelphia, Pennsylvania--(Newsfile Corp. - October 11, 2023) - A securities fraud class action complaint alleges that Integra LifeSciences Holdings Corporation (NASDAQ: IART), via certain of his officers and directors, repeatedly touted that it was on track to grow SurgiMend's market by obtaining FDA approval for use in post-mastectomy reconstruction, and that these misrepresentations caused the price of Integra common stock to trade at artificially inflated prices. Despite these claims,...
2023-10-11 7:58 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Discover Financial Services (DFS)
Philadelphia, Pennsylvania--(Newsfile Corp. - September 22, 2023) - An underlying securities fraud class action complaint alleges, Discover Financial Services (NYSE: DFS), through certain of its officers and directors, made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, it is alleged that Defendants made false and/or misleading statements and/or failed to disclose that: (i) DFS maintained deficient risk...
2023-09-22 12:09 PM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Ardelyx Inc. (ARDX)
Philadelphia, Pennsylvania--(Newsfile Corp. - September 20, 2023) - A securities class action complaint alleges that Ardelyx Inc. (NASDAQ: ARDX), via certain of its officers, made materially false and misleading statements regarding tenapanor and the likelihood that it would be approved by the FDA, which led investors to suffer significant losses. Specifically, it is alleged that on or about June 30, 2020, Ardelyx submitted a New Drug Application ("NDA") to the FDA to obtain approval to sell...
2023-09-20 1:12 PM EDT
Grabar Law Office Investigates Claims on Behalf of Vertiv Holdings Co. (VRT) Shareholders
Philadelphia, Pennsylvania--(Newsfile Corp. - September 20, 2023) - A recently filed securities fraud class action complaint alleges that Vertiv Holdings Co. (NYSE: VRT), via certain officers and directors, made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the complaint alleges that the Company, via certain officers and directors, failed to disclose to investors: (1)...
2023-09-20 1:08 PM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Horizon Bancorp, Inc. (HBNC)
Philadelphia, Pennsylvania--(Newsfile Corp. - September 20, 2023) - A recently filed securities fraud class action alleges that Horizon Bancorp, Inc. (NASDAQ: HBNC) made materially false and misleading statements about the Company's business, operations, and prospects, including those that relate to: (i) the Company maintained deficient internal accounting controls relating to its classification of certain loan balances and securities; (ii) as a result of the deficiencies, throughout 2022,...
2023-09-20 1:01 PM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of UiPath Inc. (PATH)
Philadelphia, Pennsylvania--(Newsfile Corp. - September 13, 2023) - A recently filed securities fraud class action complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) UiPath had enacted a widespread discounting program prior to its IPO, which had the effect of temporarily boosting UiPath's revenue and annualized recurring revenue metrics, cannibalizing its future sales, eroding UiPath's margins, and...
2023-09-13 1:27 PM EDT
Horizon Bancorp, Inc. Investor Alert: Grabar Law Office Investigates Claims on Behalf of Shareholders of Horizon Bancorp, Inc. (HBNC)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 30, 2023) - A recently filed securities fraud class action alleges that Horizon Bancorp, Inc. (NASDAQ: HBNC) made materially false and misleading statements about the Company's business, operations, and prospects, including those that relate to: (i) the Company maintained deficient internal accounting controls relating to its classification of certain loan balances and securities; (ii) as a result of the deficiencies, throughout 2022, the...
2023-08-30 9:29 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Co-Diagnostics, Inc. (CODX)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 23, 2023) - A securities fraud class action complaint alleges that the company, through certain of its officers and directors, repeatedly touted the Logix Smart™ COVID-19 Test, reassuring investors about the demand for the product. The Complaint further alleges that, at the same time, Defendants failed to disclose that: (1) demand for the Logix Smart™ COVID-19 Test had plummeted throughout the quarter ended June 30, 2022, and (2) as a...
2023-08-23 11:45 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of CareDx, Inc. (CDNA)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 23, 2023) - It is alleged that certain officers of CareDx, Inc. (NASDAQ: CDNA) caused the Company to issue materially false and misleading statements regarding its testing services. Specifically, it is alleged that the Company failed to disclose that certain CareDx officers had engaged in a number of improper and illegal schemes to inflate testing services revenue, including: (i) encouraging protocols for surveillance of organ rejection...
2023-08-23 10:56 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Lottery.com Inc. (LTRY) f/k/a Trident Acquisitions Corp. (TDAC)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 23, 2023) - A securities fraud class action alleges that Lottery.com (NASDAQ: LTRY), via certain of its officers and directors, made materially false or misleading statements and/or failed to disclose material information. The Complaint further alleges that: (i) the Company lacked adequate internal accounting controls; (ii) the Company lacked adequate internal controls over financial reporting, including but not limited to those pertaining...
2023-08-23 10:49 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Invivyd, Inc. ( IVVD) f/k/a Adagio Therapeutics (ADGI)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 23, 2023) - Grabar Law Office is investigating potential claims against the officers and directors of Invivyd, Inc. (NASADAQ: IVVD) f/k/a Adagio Therapeutics (NASDAQ: ADGI) on behalf of Invivyd shareholders. A class action complaint has been filed against Invivyd. The complaint alleges that defendants failed to disclose that: (i) the published epitope mapping, structural studies, and sequence analyses which defendants had used to claim...
2023-08-23 10:43 AM EDT
Grabar Law Office Investigates Claims on Behalf of Vertiv Holdings Co. (VRT) Shareholders
Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2023) - A recently filed securities fraud class action complaint alleges that Vertiv Holdings Co. (NYSE: VRT), via certain officers and directors, made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the complaint alleges that the Company, via certain officers and directors, failed to disclose to investors: (1) that...
2023-08-22 9:38 AM EDT
Grabar Law Office Investigates Claims on Behalf of TaskUs, Inc. (TASK) Shareholders
Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2023) - A recently filed securities fraud class action complaint alleges TaskUs, Inc. (NASDAQ: TASK), via certain of its officers and directors, made materially false and misleading positive statements about its business, when in truth: (1) TaskUs was experiencing severe financial strain and business challenges; (2) the Content Security market was smaller than Defendants represented and Defendants' representations were based on outdated...
2023-08-22 9:15 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of PureCycle Technologies, Inc. (PCT) fka Roth CH Acquisition I Co (ROCH)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2023) - A federal securities fraud class action complaint alleges that PureCycle Technologies, Inc. (NASDAQ: PCT), via certain officers and directors, made false and/or misleading statements and/or failed to disclose that: (i) the technology PureCycle licensed from Procter & Gamble is not proven and presents serious issues even at lab scale; (ii) the challenges posed by the availability and competition for the raw materials necessary to...
2023-08-22 9:10 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of FirstCash Holdings, Inc. (FCFS)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2023) - A securities fraud class action complaint has alleged that FirstCash Holdings, Inc. (NASDAQ: FCFS) failed to disclose adverse facts about FirstCash's business, operations and prospects, which were known to, or recklessly disregarded by the company and its officers and directors. These adverse facts include: that FirstCash had made more than 3,600 loans to over 1,000 active-duty members of the military and their families at...
2023-08-22 9:04 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Bright Health Group, Inc. (BHG)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2023) - A securities fraud class action complaint alleges Bright Health Group, Inc.'s (NYSE: BHG) IPO Offering Documents contained untrue statements of material fact and that Bright Health, through certain of its officers and directors, made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, the underlying securities fraud complaint alleges that Bright Health...
2023-08-22 8:57 AM EDT
Grabar Law Office Investigates Claims on Behalf of Shareholders of Ardelyx Inc. (ARDX)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2023) - A securities class action complaint alleges that Ardelyx Inc. (NASDAQ: ARDX), via certain of its officers, made materially false and misleading statements regarding tenapanor and the likelihood that it would be approved by the FDA, which led investors to suffer significant losses. Specifically, it is alleged that on or about June 30, 2020, Ardelyx submitted a New Drug Application ("NDA") to the FDA to obtain approval to sell and...
2023-08-21 9:09 AM EDT